top of page
Ancla 1
A.jpg

Our Platform

Two different lung-specific bacterial chassis (MycoChassis and LactoChassis), designed to treat acute and chronic respiratory diseases, respectively. These chassis are able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner.

Pulmoproteinas.png

IMMUNE SYSTEM MODULATION

LC_08.png

Lung Cancer

Immune stimulatory interleukins, nanobodies against immune check point inhibitors

LC_02.png

Asthma

Modified interleukins

nanobodies

LC_03.png

Pulmonary alveolar proteinosis

GM-CSF mutants

ANTIMICROBIAL AND BIOFILM DISPERSION

ACUTE

LC_03.png

Cystic Fibrosis

Infectious diseases

Antibacterial and

biofilm-dispersing agents

LC_09.png

VAP

Infectious diseases

Antibacterial and

biofilm-dispersing agents

PROTEIN SUPPLEMENTATION

FOR GENETIC DISEASES

LC_05.png

Chronic obstructive

Pulmonary disease

A1AT

LC_06.png

Interstitial lung disease

Surfactant proteins

bottom of page